Bloom syndrome (BSyn), also known as Bloom-Torre-Machacek syndrome or Congenital Telangiectatic Erythema, is a rare, inherited genetic disorder.

Bloom syndrome is a rare hereditary genetic disease characterized by short stature, reduced fertility, reddish lesions on the skin upon being exposed to sun and increased risk of cancer ...

Two independent papers in the October 15th issue of G&D detail the discovery of a previously unidentified fourth component of the Bloom's syndrome complex. Bloom's syndrome is an inherited cancer ...

These include the rare condition Bloom syndrome, which causes varying degrees of immunodeficiency as well as sun sensitivity, telangiectatic erythema of the face, and stunted growth.

The U.S. Food and Drug Administration has given 23andMe clearance to begin selling kits for the genetic testing of Bloom Syndrome. This is a rare recessive gene disorder that is characterized by ...

The U.S. Food and Drug Administration has allowed Google-backed company 23andMe to begin marketing a home genetic test for Bloom Syndrome.

The Food and Drug Administration (FDA) has approved for marketing 23andMe's Bloom Syndrome carrier test to determine whether a healthy person expresses a gene variant that could lead to their ...

In January, the two doctors, who work out of Ohio State University, received a grant from the Milo Gladstein Foundation for Bloom’s Syndrome, making their lab the world’s largest center for ...

Bloom syndrome is a disease characterized by increased tumorigenesis, immunodeficiency and partial sterility. It is caused by mutations in the BLM gene, which encodes a helicase. In the March 30th ...

Bloom's syndrome is an inherited cancer predisposition disease, resulting from mutations in a gene on the long arm of chromosome number 15.